Clinical Utility of Applying PGx and Deprescribing-Based Decision Support in Polypharmacy : Future Perspectives
| Clinical Utility of Applying PGx and Deprescribing-Based Decision Support in Polypharmacy : Future Perspectives |
| Autore | Vermehren Charlotte |
| Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica | 1 online resource (224 p.) |
| Soggetto topico |
Manufacturing industries
Medicine and Nursing |
| Soggetto non controllato |
2019 Beers criteria
5'nuclease assay 80 and over abacavir acute kidney injury adverse drug reaction adverse drug reactions aged allopurinol antidepressants antiepileptic drugs antipsychotics appropriateness bleeding children chronic clinical pharmacist clozapine CNV copy number variation cost-effectiveness CYP1A2 CYP2D6 CYP2D7P CYP2D8P cytochrome P450 cytochromes deprescribing deprescriptions determinants digital decision-support digital health DOACs drug hypersensitivity drug information service drug interaction checkers drug metabolization drug-drug interactions drug-gene interactions early biomarker electronic medical record electronic prescribing emergency department Ethiopia exosomes extracellular vesicles flucloxacillin general practice genotyping health outcomes health services research high resolution melting HLA hospital pharmacy service HRM loxapine medication adherence medication optimization medication reconciliation medication review medication-based risk score microvesicles multimorbidity nursing homes olanzapine older adults older patients outpatient personalized medicine persons with diabetes pharmacogene expression pharmacogenetics pharmacogenomics phenprocoumon plasma neutrophil gelatinase-associated lipocalin polypharmacy population-based potentially inappropriate medication use prevalence process evaluation quality of life shared medication record SLCO1B1 soluble urokinase plasminogen activator receptor thromboembolism utility youth |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Clinical Utility of Applying PGx and Deprescribing-Based Decision Support in Polypharmacy |
| Record Nr. | UNINA-9910595072903321 |
Vermehren Charlotte
|
||
| Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Drug-Drug Interactions
| Drug-Drug Interactions |
| Autore | Kim Dong Hyun |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
| Descrizione fisica | 1 online resource (242 p.) |
| Soggetto topico |
Biology, life sciences
Research & information: general |
| Soggetto non controllato |
(‒)-sophoranone
1A2 2B6 2C19 2C8 2C9 2D6 3A4 ADME adverse drug reactions biflavonoid chronic kidney disease competitive inhibition computational prediction CYP CYP1A1 CYP1A2 CYP2C9 CYP2D6 CYP3A CYP3A4 cytochrome P450 cytochromes P450 DDI Dexamethasone drug interaction drug interactions drug metabolism drug transporter drug-drug interaction drug-drug interactions expression fexofenadine gepants high plasma protein binding in silico in vitro in vivo inhibitor ixazomib Ketoconazole lasmiditan Lexicomp low permeability Loxoprofen mechanism-based inhibition metabolic DDI metabolism migraine monoclonal antibodies non-competitive inhibition O-desmethyltramadol OATP1B1 OATP1B3 organic anion transporting polypeptide 1A2 (OATP1A2) P-glycoprotein (P-gp) P450 pharmacokinetics physiologically-based pharmacokinetics plasma concentration polypharmacy potent inhibition QSAR regulation Rumex acetosa selamariscina A signal detection algorithms spontaneous reporting systems subset analysis substrate systemic exposure tadalafil ticagrelor tissue-specific tramadol tyrosine kinase inhibitors ubiquitination uridine 5'-diphosphoglucuronosyl transferase |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557666403321 |
Kim Dong Hyun
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
The Impact of Caffeine and Coffee on Human Health
| The Impact of Caffeine and Coffee on Human Health |
| Autore | Cornelis Marilyn |
| Pubbl/distr/stampa | MDPI - Multidisciplinary Digital Publishing Institute, 2019 |
| Descrizione fisica | 1 online resource (322 p.) |
| Soggetto topico | Biology, life sciences |
| Soggetto non controllato |
24-h dietary recall
accidental death adenosine adenosine receptor ADORA2A adult age aging alcohol consumption anxiety assisted reproduction techniques behavior bias biomarkers caffeine Caffeine caffeine intake caffeine intoxication caffeine metabolism cardiovascular disease causality causation chlorogenic acids chocolate clinical pregnancy coffee coffee consumption cognition cognitions cognitive cohort study consumption coronary artery disease country CYP1A2 cytochrome P450 depression did not respond dipyridamole energy drinks epidemiological methods epidemiology ergogenic ergogenic aid European Prospective Investigation into Cancer and Nutrition exercise expectancy gene expression gene-diet interaction genetic epidemiology guidelines health hearing HIV-HCV co-infection implantation individual responses intoxication lipidomics lipids live birth liver fibrosis longevity lysophosphatidylcholine mate Mendelian Randomization mood mRNA myocardial perfusion n/a NADH dehydrogenase pharmacogenomics pharmacological ergogenic aid phenolic placebo polymorphism population pregnancy protection public policy regadenoson responders risk factors safety serum chloride levels sex soda sport Suicide supplement systematic review tea the Norwegian Women and Cancer Cohort (NOWAC) time trial performance tinnitus transcriptomics trial whole-blood wine |
| ISBN | 3-03921-835-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910367738403321 |
Cornelis Marilyn
|
||
| MDPI - Multidisciplinary Digital Publishing Institute, 2019 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||